Fluid overload in patients undergoing TAVR: what we can learn from the nephrologists.
Christian NitscheAndreas Anselm KammerlanderMatthias KoschutnikLeah SinnhuberNabila ForutanAnna EidenbergerCarolina DonàFlorian SchartmuellerVarius DannenbergMax Paul WinterJolanta M Siller-MatulaAnahit Anvari-PirschGeorg GoliaschChristian HengstenbergJulia MascherbauerPublished in: ESC heart failure (2021)
In patients undergoing TAVR, FO by BIS is strongly associated with adverse outcomes. BIS measurement conveys prognostic information not represented in any currently used AS/TAVR risk assessments.